Companies: 10,795·Total market cap: $144.5T
Virax Biolabs Group Limited

Virax Biolabs Group Limited

VRAXNASDAQHealthcare● Active
$0.19
$-0.02(-9.87%)
Market Cap$817156
P/E Ratio—
52W High$1.14
52W Low$0.1
EmployeesOwnershipInsider Trades

Virax Biolabs Group Limited (VRAX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · VRAX · as of Jul 2, 2025

Latest filing snapshot

19
+2+11.76%vs prior year

Virax Biolabs Group Limited (VRAX) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-03-31·Full-time · Global
Total Employees
19
Change (1Y)
+2
Growth % (1Y)
+11.76%
Revenue / Employee
$333
Net Income / Employee
$-319.0K
Market Cap
$1M

VRAX Employee Count

2022 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-07-0219+2+11.76%
2024-08-2017+6+54.55%
2023-06-1411+6+120.00%
2022-08-125——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Moolec Science S.A.
MLEC
Moolec Science S.A.
52#2
Virax Biolabs Group Limited
VRAX
Virax Biolabs Group LimitedYOU
19#3
Dermata Therapeutics, Inc.
DRMA
Dermata Therapeutics, Inc.
8#4
Artelo Biosciences, Inc.
ARTL
Artelo Biosciences, Inc.
6#5
Avenue Therapeutics, Inc.
ATXI
Avenue Therapeutics, Inc.
2#6
PMGC Holdings Inc.
ELAB
PMGC Holdings Inc.
2#7
GT Biopharma, Inc.
GTBP
GT Biopharma, Inc.
1
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · VRAX peer comparison

About VRAX employees

VRAX Employees · Headcount

Virax Biolabs Group Limited (VRAX) employee data is sourced from the annual SEC 20-F filing. As of 2025, Virax Biolabs Group Limited had 19 full-time employees globally. Full-time employees only. Global consolidated headcount.

Virax Biolabs Group Limited employs 19 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $333, reflecting the company's operational efficiency.

Virax Biolabs Group Limited's workforce increased by 2 (11.76%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Virax Biolabs Group Limited's revenue per employee of $333 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

VRAX Employees · 5 questions

As of the latest SEC 20-F filing (2025), Virax Biolabs Group Limited had 19 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Virax Biolabs Group Limited employee counthow many employees does Virax Biolabs Group Limited haveVRAX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-07-02